Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
Genesis Therapeutics’ $200 Million Series B Funding Round
Consilio’s Combination With Xact Data Discovery
Debevoise & Plimpton LLP advised Stone Point Capital, while Willkie Farr & Gallagher LLP advised Aquiline Capital Partners on the deal. Kirkland & Ellis advised GI...
Twilio’s Partnership with and Investment in Syniverse
Debevoise & Plimpton advised The Carlyle Group, as majority owner of Syniverse, while Kirkland & Ellis LLP and DLA Piper LLP advised Twilio on the deal....
Twilio’s Partnership with and Investment in Syniverse
Debevoise & Plimpton advised The Carlyle Group, as majority owner of Syniverse, while Kirkland & Ellis LLP and DLA Piper LLP advised Twilio on the deal....